Amylyx Pharmaceuticals (AMLX) Other Non Operating Income (2021 - 2025)
Historic Other Non Operating Income for Amylyx Pharmaceuticals (AMLX) over the last 5 years, with Q3 2025 value amounting to -$180000.0.
- Amylyx Pharmaceuticals' Other Non Operating Income fell 2765.96% to -$180000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$904000.0, marking a year-over-year increase of 2466.67%. This contributed to the annual value of -$1.2 million for FY2024, which is 8393.94% down from last year.
- As of Q3 2025, Amylyx Pharmaceuticals' Other Non Operating Income stood at -$180000.0, which was down 2765.96% from -$546000.0 recorded in Q2 2025.
- In the past 5 years, Amylyx Pharmaceuticals' Other Non Operating Income registered a high of $261000.0 during Q1 2021, and its lowest value of -$747000.0 during Q1 2024.
- In the last 5 years, Amylyx Pharmaceuticals' Other Non Operating Income had a median value of -$141000.0 in 2024 and averaged -$186157.9.
- In the last 5 years, Amylyx Pharmaceuticals' Other Non Operating Income skyrocketed by 18766.52% in 2022 and then crashed by 127894.74% in 2023.
- Amylyx Pharmaceuticals' Other Non Operating Income (Quarter) stood at -$59000.0 in 2021, then crashed by 1067.8% to -$689000.0 in 2022, then soared by 124.82% to $171000.0 in 2023, then fell by 8.19% to $157000.0 in 2024, then crashed by 214.65% to -$180000.0 in 2025.
- Its last three reported values are -$180000.0 in Q3 2025, -$546000.0 for Q2 2025, and -$335000.0 during Q1 2025.